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a b s t r a c t
We describe an 86-year-old woman with a history of hypertension who presented sudden
disturbances of consciousness and left hemiparesis. Brain magnetic resonance imaging
(MRI) revealed diffused hyperintensive changes on T2-weighted images localized subcorti-
cally in the white matter of both cerebral hemispheres, corresponding to acute vasogenic
edema, causing moderate mass effect. Posterior reversible encephalopathy syndrome was
initially diagnosed. After implementation of anti-edema intravenous steroid treatment and
hypotensive therapy the symptoms began to retire, till the total regression. The successive
hospitalizations took place two and eight months later due to the occurrence of seizures,
motor deﬁcits and the development of mild cognitive impairment. Brain MRI revealed
progression of the white matter changes and diffused subcortical microhemorrhages. Each
time pulse steroid therapy was implemented and the symptoms improved signiﬁcantly after
several days. Chronic oral steroid treatment resulted in the stabilization of neurological
status. The long-term observation of clinical symptoms, remission after immunosuppres-
sive therapy and white matter changes with subcortical microhemorrhages in brain MRI
leaded to the diagnosis of cerebral amyloid angiopathy-related inﬂammation.
© 2018 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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Posterior reversible encephalopathy syndrome (PRES) may be
initially suspected when alterations in consciousness and* Corresponding author at: Department of Neurology, Medical Univers
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genic edema on brain magnetic resonance imaging (MRI). The
syndrome is typically presented by headache, seizures, visual
impairment, focal neurological deﬁcits and mental state
changes [1,2]. It is most commonly encountered in association
with acute hypertension, preeclampsia or eclampsia, renality of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.
a-Oleszkiewicz).
eurological Society.
Fig. 1 – Brain CT scan on first admission.
Fig. 2 – First hospitalization – diffused hyperintensive changes on T2-weighted images localized subcortically in the white
matter of both cerebral hemispheres (A–C), vasogenic edema in DWI option (D).
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Brain MRI reveals characteristic hyperintensive changes on
T2-weighted and FLAIR images corresponding to the vasogenic
edema. They are mainly located in subcortical white matter,
less often in cerebral cortex. Classically, the changes are placed
in parieto-occipital areas, less commonly in frontal or
temporal lobes, basal ganglia, thalamus, mesencephalon,
brainstem or cerebellum [1,3]. In most cases the edema is
bilateral and symmetric, but can also be unilateral [1].
In the presented case report PRES was initially diagnosed
but subsequently differential diagnosis of cerebral amyloid
angiopathy-related inﬂammation (CAA-RI) was considered
due to their distinctive clinical presentation and neuroimaging
results.
Cerebral amyloid angiopathy (CAA) refers to the deposits of
b-amyloid in small and mid-sized arteries and veins of the
cerebral cortex and leptomeninges, without associated sys-
temic amyloidosis [4]. Amyloid depositions in the vascular
media and adventitia may lead to vessel fragility, rupture and
intracerebral hemorrhages, which are frequently recurrent,
especially in individuals aged over 55 with normal arterial
blood pressure [6]. One of the manifestations of CAA is CAA-RI
[5–7]. It is an immune reaction to the deposits of b-amyloid
with corresponding inﬂammatory process. It is presented
commonly by seizures, subacute cognitive impairment, head-
aches and good response to immunosuppressive treatment
[6]. Asymmetric T2-weighted or FLAIR hyperintensities in
cortex or subcortical white matter with multiple microhemor-
rhages in brain imaging are characteristic for CAA-RI [6].
Recently, the similarity of CAA-RI and amyloid-related
imaging abnormalities (ARIA) reported in Alzheimers's disease
(AD) passive immunization therapies was described [8,9]. It
was observed that anti-amyloid b (Ab) autoantibodies inFig. 3 – EEG on admission during the first hospitalizacerebrospinal ﬂuid (CSF) may be produced as a response to b-
amyloid immunotherapy trials of AD and that they are also
found in CAA-RI [8,9]. Therefore, CAA-RI is considered as a
human spontaneous model of drug-induced ARIA [8–10] and
thus Ab autoantibodies in CSF may be a potential biological
marker of CAA-RI [10]. Moreover, the prevalence of 80% of
APOE e4 genotype in patients with CAA-RI was described [8–
10].
In this study we set out to determine clinical features and
characteristic radiologic imaging in an appropriate differential
diagnosis between PRES and CAA-RI, in order to avoid the
delay of reaching to the correct ﬁnal diagnosis.
2. Case report
An 86 year-old woman with a history of hypertension was
admitted to the Emergency Department due to sudden
occurrence of consciousness disturbances and left hemipar-
esis. At admission arterial blood pressure was 160/80 mmHg.
During subsequent days the neurological deﬁcit was escalat-
ing – severe disturbances of consciousness and left hemipar-
esis with Babinski sign on both sides occurred.
Brain computed tomography revealed extensive hypo-
dense changes in the white matter of fronto-parietal region
bilaterally with the predominance on the right side (Fig. 1). The
traits of moderate cerebral edema were reported. These
ﬁndings prompted further neuroradiological examinations.
The brain MRI with Gadolinum presented diffused hyper-
intensive changes on T2-weighted images localized subcorti-
cally in the white matter of both hemispheres, with the
predominance in the parietal lobes and right frontal lobe
(Fig. 2). Appearance of the changes in diffusion-weightedtion – severe generalized changes with slowing.
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coefﬁcient (ADC) map did not show areas of restricted
diffusion. There was no Gadolinum enhancement. The slight
mass effect manifested as a compression of the right lateral
ventricle. At that time, susceptibility weighted imaging
sequence (SWI) was not assessed. The electroencephalogra-
phy (EEG) revealed severe generalized changes with slowing
(Fig. 3). In CSF there were high protein concentration (90 mg%),
cytosis 1.6/ml, 93% of active monocytoid cells with the
dominance of CD14 cells, 7% of lymphocytes and few
erythrocytes. No cytomegalovirus and herpes virus DNA were
found. The presence of JC virus was not tested. According to
the neuroimaging ﬁndings the diagnosis of PRES or gliomatosis
cerebri was suggested. In order to exclude the neoplastic cause
the MRI spectroscopy with contrast was performed in which
no characteristics of gliomatosis cerebri were found.
The anti-edema treatment by intravenous pulses of
dexamethazone was implemented (3  4 mg i.v. for ﬁve days)Fig. 4 – Second hospitalization – acute vasogenic edema of right
weighted images (A–C), diffused subcortical microhemorrhages with no serious adverse effects. Left hemiparesis and
disturbances of consciousness began to retire, till the total
regression of the neurological symptoms. Follow-up brain MRI
after 16 days revealed less intensiﬁed hyperintensive changes
on T2-weighted images and no mass effect. EEG two weeks
after admission showed less intensiﬁed changes than previ-
ously. During the hospitalization the arterial blood pressure
was normal. No seizures were observed. The patient was
discharged home with normal neurological examination.
Two months later the patient presented again to the
Emergency Department with acute disturbances of conscious-
ness and left hemiparesis which occurred after an episode of
seizures with involuntary urination and defecation. The
symptoms lasted for few hours. Brain MRI revealed acute
vasogenic edema of right temporal lobe (Fig. 4). Changes on T2-
weighted images in frontal and parietal lobes were comparable
to those from the previous month. Except them, in the affected
brain areas the small, diffuse changes without signal intensi- temporal lobe and diffused hyperintensive changes on T2-
with hemosyderine deposits in SWI option (D).
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corresponded to micro-hemorrhagic lesions. There was no
Gadolinum enhancement. Obtained images suggested CAA
coexisting with persisting white matter hyperintensities after
PRES or recurring PRES. EEG on admission revealed generalized
slowing with a tendency to synchronization (Fig. 5). As a result,
oral levetiracetam 2  1 g was started. Follow-up EEG after 10
days presented less intensiﬁed changes. After implementation
of intravenous pulses of methyloprednisolone (1  1 g i.v. for
ﬁve days) with no serious adverse effects, the patient was
discharged without any neurological disturbances.
The last, third hospitalization took place eight months
later. The patient was found unconscious and with tetrapar-
esis after a seizure attack with involuntary urination and
defecation. According to the testimony of the family, during
last few months the patient began to present progressive
subacute dementia. On admission she presented disturbances
of consciousness with no evident motor deﬁcits. The brain MRI
revealed large conﬂuent areas of predominantly white matter
hyperintense signal on T2-weighted images in both cerebral
hemispheres and multiple, scattered, subcortical microhe-
morrhages with hemosyderine deposits in SWI and a mass
effect (Fig. 6). No Gadolinum enhancement was observed.
Results of brain MRI images showed a signiﬁcant progression
of changes comparing to previous images. Presence of these
ﬁndings suggested CAA-RI. EEG showed severe generalized
changes with a slight predominance in right hemisphere with
slowing (Fig. 7). In CSF examination there were high protein
concentration (75 mg%), cytosis 4/ml, 57% of active monocytoid
cells, 39% of lymphocytes, 4% of segmented neutrophils, 2
erythrophages and few erythrocytes. In blood and CSF
samples, the antibodies which could be responsible forFig. 5 – EEG on admission during the second hospitalization – g
changes are more intensified than during the previous EEG.encephalopathy or encephalitis (NMDA, AMPA1, AMPA2,
DPPX, LGI1, CASPR2, GABA, JCV-DNA) were not found. The
concentrations of inﬂammatory markers – procalcitonine and
CRP – were 0.03 ng/ml and 16.6 mg/l respectively.
The neurological symptoms normalized after intravenous
pulses of methyloprednisolone (1  1 g i.v. for ﬁve days, with
no serious adverse effects), despite a mild cognitive im-
pairment. The patient was dismissed on oral hydrocortisone
3  20 mg and levetiracetam 2  1 g. To our best knowledge the
patient had no seizures till this moment. The subacute
progression of cognitive functions is being observed. The
treatment by hydrocortisone 2  20 mg is being continued.
3. Discussion
The presented case report shows the diagnostic difﬁculties in a
patient with uncommon and misleading initial presentation of
CAA-RI.
During the ﬁrst hospitalization the largely symmetric
cortical and subcortical vasogenic edema in brain MRI and
the clinical symptoms which occurred acutely, withdrew
completely. Such course strongly suggested PRES. Moreover,
the blood pressure on admission and severe generalized
changes with slowing in EEG [11] argued in favor of this
syndrome.
The second hospitalization, which was caused by a
transient hemiparesis after seizure attack, gave us a deeper
insight into the etiology of these neurological disturbances.
Due to asymmetric acute vasogenic edema of cerebral white
matter with numerous microhemorrhages CAA or CAA-RI
were suggested, nevertheless, the suggestion of atypicaleneralized slowing with a tendency to synchronization, the
Fig. 6 – Third hospitalization – white matter hyperintense signal on T2-weighted images in both hemispheres (A–C), multiple,
scattered, subcortical microhemorrhages with hemosyderine deposits in SWI option (D).
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of the white matter hyperintesities was more characteristic for
CAA-RI than for PRES, where lesions are most commonly
symmetric [3,6]. Although hemorrhages in the affected regions
may be observed in both diseases [3] cortical and subcortical
microhemmorhages are characteristic for CAA-RI. In addition,
the CSF examination which revealed presence of active
monocytoid cells, can suggest CAA-RI [12]. Moreover, the
moderate hypertension is not a typical risk factor of PRES [3].
The third hospitalization was provoked by similar clinical
symptoms as two previous ones, however they lasted longer
than before. Brain imaging revealed the signiﬁcant progression
of white matter changes with hemosiderine deposits indicat-
ing past microhemorrhages. Developing changes exclude the
diagnosis of PRES in this situation and indicate the progression
of changes due to recurring CAA-RI. The presence of micro-
hemorrhages with the history of asymmetric white matter
changes with good response to immunsupresive therapy and
typical clinical presentation indicate strongly CAA-RI [6].In 2011 Chung et al. [13] proposed diagnostic criteria for
deﬁnite and probable CAA-RI based on a review of clinical,
imaging and biopsy ﬁndings. These criteria were recently
validated in biopsy-proven cases by Auriel et al. [14] who
suggested reliable diagnosis of CAA-RI based on typical clinical
features and extensive white matter hyperintensities, without
histopathological examination, with good sensitivity and
speciﬁcity (Table 1). The presented case fulﬁlls the criteria
for probable CAA-RI. Nevertheless, even though the reliable
diagnosis can be reached using these criteria, still the
neuropathological conﬁrmation remains the deﬁnitive diag-
nostic approach to CAA-RI [14].
The treatment of CAA-RI should be implemented without
brain biopsy in patients with probable CAA-RI [14]. There are
no strict recommendations for the therapy, however the high
dose corticosteroids at the beginning and the chronic
treatment by immunosuppressive agents or corticosteroids
after the clinical and radiological improvement are believed to
be the most reasonable [6,10,13,14]. The brain biopsy should be
Table 1 – Diagnostic criteria of CAA-RI, after Auriel et al. [14].
Probable CAA-RI 1. Age ≥40 years.
2. Presence of ≥1 of the following clinical features: headache, decrease on consciousness, behavioral change,
or focal neurological signs and seizures, the presentation is not directly attributed to an acute intracranial
hemorrhage (ICH).
3. MRI shows unifocal or multifocal white matter lesions that are asymmetric and extend to the immediately
subcortical white matter, the asymmetry is not due to past ICH
4. Presence of ≥1 of the following corticosubcortical hemorrhagic lesions: cerebral macrohemorrhages,
cerebral microhemorrhages, or cortical superﬁcial siderosis
5. Absence of neoplastic, infectious, or other cause.
Possible CAA-RI 1. Age ≥40 years.
2. Presence of ≥1 of the following clinical features: headache, decrease on consciousness, behavioral change,
or focal neurological signs and seizures, the presentation is not directly attributed to an acute intracranial
hemorrhage (ICH).
3. MRI shows white matter lesions that extend to the immediately subcortical white matter
4. Presence of ≥1 of the following corticosubcortical hemorrhagic lesions: cerebral macrohemorrhages,
cerebral microhemorrhages, or cortical superﬁcial siderosis
5. Absence of neoplastic, infectious, or other cause.
Fig. 7 – EEG on admission during the third hospitalization – severe generalized changes with a slight predominance in right
hemisphere (frontal lobe) with intensive slowing.
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therapy within 3 weeks [14]. In our case the response to short
high-dose corticosteroid therapy was signiﬁcant and the
chronic therapy with hydrocortisone gave the stabilization
of the clinical status of the patient, thus further supporting the
diagnosis of CAA-RI.
Typically CAA-RI has monophasic pattern, the relapses
were reported occasionally [6,15,16]. To our best knowledge,
this is a ﬁrst presentation of a patient who suffered from
CAA-RI three times in a short period of time – all previouslyreported cases depicted one recurrence ranging from 3
months to 8 years after the ﬁrst episode [16]. The ﬁrst
recurrence of CAA-RI affected different lobe than the initial
event, while the second one was observed both in the same
and new cerebral regions.
Cerebral microhemorrhages observed in CAA-RI might be
seen in various diseases [17]. In our case, having in mind good
response to steroid therapy, primary central nervous system
vasculitis (PCNSV) should be considered [16]. Conﬂuent
hyperintesities in T2-weighted images without the evidence
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RI [16].
Moreover, the ﬂaw of this case report is the fact that anti-Ab
autoantibodies in CSF and APOE e4 allele were not examined.
These ﬁndings would make ﬁnal diagnosis more clear and give
more details about the pathogenesis of CAA-RI in this case.
What is more, the evaluation of b-amyloid depositions in
vessels can be determined using 11C-Pittsburgh Compound B-
positron emission tomography (PiB PET) [15]. This examina-
tion can be additionally used in the evaluation of the deposits
in different brain areas during acute CAA-RI and in case of a
relapse. [15].
4. Conclusions
We present a patient with recurrent CAA-RI with clinical
improvement after steroid therapy, who was ﬁrst believed to
suffer from PRES. Asymmetric bilateral hyperintensities in T2-
weighted images and subcortical/cortical microhemorrhages
in SWI in brain MRI were crucial for establishing the suspicion
of CAA-RI. To conclude, this rare and under-recognized ﬁnal
diagnosis was reached due to the results of neuroimaging,
improvement after immunosuppressive therapy and long-
term observation of clinical symptoms.
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